We are live on ! Find out more
BM

Brandywine Managers Portfolio holdings

AUM $202M
1-Year Est. Return 16.99%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$104M
AUM Growth
+$3.62M
Cap. Flow
-$109K
Cap. Flow %
-0.1%
Top 10 Hldgs %
83.52%
Holding
39
New
3
Increased
2
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
FIG
Figma
FIG
+$994K
2
HTFL
Heartflow Inc
HTFL
+$539K
3
RNAM
Avidity Biosciences
RNAM
+$507K
4
KVYO icon
Klaviyo
KVYO
+$140K
5
VKTX icon
Viking Therapeutics
VKTX
+$126K

Top Sells

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$570K
2
ISRG icon
Intuitive Surgical
ISRG
+$432K
3
NTRA icon
Natera
NTRA
+$324K
4
NVO
Novo Nordisk
NVO
+$259K
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$204K

Sector Composition

Rank Sector Weight
1 Technology 49.28%
2 Miscellaneous 38.94%
3 Healthcare 10.81%
4 Financials 0.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PD icon
26
PagerDuty
PD
$1.07B
$504K 0.48%
30,517
– –
KVYO icon
27
Klaviyo
KVYO
$5.3B
$481K 0.46%
17,384
+4,346
+33% +$140K
BEAM icon
28
Beam Therapeutics
BEAM
$3.06B
$452K 0.43%
18,606
– –
SDGR icon
29
Schrodinger
SDGR
$1.5B
$419K 0.4%
20,886
– –
OKTA icon
30
Okta
OKTA
$29.8B
$386K 0.37%
4,209
-6,100
-59% -$570K
VKTX icon
31
Viking Therapeutics
VKTX
$4.07B
$323K 0.31%
12,301
+4,219
+52% +$126K
GPCR icon
32
Structure Therapeutics
GPCR
$3.38B
$310K 0.3%
11,057
– –
MRNA icon
33
Moderna
MRNA
$58.1B
$246K 0.24%
9,510
– –
TWLO icon
34
Twilio
TWLO
$35.8B
$236K 0.23%
2,357
– –
TXG icon
35
10x Genomics
TXG
$8.16B
$221K 0.21%
18,938
– –
RLAY icon
36
Relay Therapeutics
RLAY
$4.17B
$201K 0.19%
38,429
– –
ABCL icon
37
AbCellera Biologics
ABCL
$3.7B
$143K 0.14%
28,488
– –
NVO
38
Novo Nordisk
NVO
$206B
– –
-3,747
Closed -$259K
S icon
39
SentinelOne
S
$6.92B
– –
-10,501
Closed -$192K
1
2

Similar funds

OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
WPW
Winthrop Partners - WNY Buffalo, New York $202M AUM
HWA
Hilltop Wealth Advisors Chapel Hill, North Carolina $202M AUM 24.55% 1-Year Est. Return
DFG
Delphi Financial Group Wilmington, Delaware $202M AUM 21.25% 1-Year Est. Return
LAMC
Longview Asset Management (California) San Rafael, California $202M AUM 11.36% 1-Year Est. Return
FC
Farringdon Capital London, United Kingdom $202M AUM 4.1% 1-Year Est. Return
ER
EVR Research Richmond, Virginia $203M AUM 60.82% 1-Year Est. Return
MRCM
Mill Road Capital Management Greenwich, Connecticut $203M AUM 79.43% 1-Year Est. Return

Brandywine Managers's Q3 2025 Portfolio in Review

As of Q3 2025, Brandywine Managers held 39 positions worth $104M, up 3.6% from $101M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Brandywine Managers's Q3 2025 filing shows 3 new, 2 increased, 7 reduced and 2 closed positions. Its largest new stake was Figma: 14,478 shares worth $751K. The largest sale was Okta, an estimated $570K.

By sector, the portfolio is most concentrated in Technology at 49% of assets, down from 51% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Brandywine Managers's largest Q3 2025 buy was Figma: 14,478 shares worth $751K.
  • Brandywine Managers added most to Klaviyo in Q3 2025, an estimated $140K increase.
  • Brandywine Managers's biggest Q3 2025 reduction was Okta, cutting an estimated $570K.
  • Brandywine Managers fully exited Novo Nordisk in Q3 2025, selling an estimated $259K.
  • Brandywine Managers's ten largest holdings make up 84% of its $104M portfolio in Q3 2025.
  • Brandywine Managers opened 3 new positions and closed 2 in Q3 2025.
  • Brandywine Managers's portfolio value rose 3.6% quarter-over-quarter to $104M.

Based on Brandywine Managers's 13F filing for Q3 2025, filed 14 Nov 2025.